$13 Billion is the total value of Perceptive Advisors's 292 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 29.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $969,472,000 | +113.2% | 90,000,000 | +100.0% | 7.48% | +13.2% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $963,396,000 | +60.7% | 6,567,566 | +93.9% | 7.43% | -14.7% |
| New | LIANBIOsponsored ads | $693,862,000 | – | 112,639,920 | +100.0% | 5.35% | – | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $613,524,000 | +141.9% | 53,118,886 | +100.0% | 4.73% | +28.4% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $601,196,000 | +95.4% | 9,699,824 | +100.0% | 4.64% | +3.8% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $386,684,000 | +36.5% | 20,255,882 | +76.3% | 2.98% | -27.6% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $374,602,000 | +74.8% | 3,476,280 | +77.6% | 2.89% | -7.2% |
| Buy | COLLEGIUM PHARMACEUTICAL INCnote 2.625% 2/1 | $338,626,000 | +87.9% | 35,000,000 | +100.0% | 2.61% | -0.2% | |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $329,822,000 | +119.8% | 10,173,454 | +100.0% | 2.54% | +16.7% |
| MGTX | Buy | MEIRAGTX HLDGS PLC | $329,904,000 | +260.2% | 13,896,554 | +100.0% | 2.54% | +91.3% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $293,392,000 | +251.7% | 10,327,034 | +160.6% | 2.26% | +86.7% |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $250,904,000 | +219.3% | 6,345,570 | +91.5% | 1.94% | +69.6% |
| VBIV | Buy | VBI VACCINES INC CDA | $244,926,000 | +43.1% | 104,670,004 | +90.2% | 1.89% | -24.0% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $237,814,000 | -34.6% | 14,257,510 | +83.8% | 1.83% | -65.3% |
| ISEE | Buy | IVERIC BIO INC | $216,692,000 | +78.6% | 12,960,000 | +73.5% | 1.67% | -5.2% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $215,058,000 | +138.2% | 5,855,130 | +101.4% | 1.66% | +26.5% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $208,506,000 | – | 2,360,000 | +100.0% | 1.61% | – |
| Buy | NEVRO CORPnote 2.750% 4/0 | $203,040,000 | +60.8% | 18,000,000 | +100.0% | 1.57% | -14.6% | |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $201,958,000 | +79.8% | 6,899,830 | +56.6% | 1.56% | -4.5% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $172,616,000 | +124.7% | 10,815,596 | +126.3% | 1.33% | +19.3% |
| OM | Buy | OUTSET MED INC | $171,768,000 | +74.5% | 3,726,794 | +87.2% | 1.32% | -7.3% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $150,668,000 | +387.6% | 4,822,894 | +138.5% | 1.16% | +158.8% |
| LABP | Buy | LANDOS BIOPHARMA INC | $142,750,000 | -34.2% | 29,739,830 | +100.0% | 1.10% | -65.1% |
| CCCC | Buy | C4 THERAPEUTICS INC | $142,252,000 | +41.0% | 4,417,826 | +95.6% | 1.10% | -25.2% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $137,272,000 | +577.2% | 2,903,400 | +372.1% | 1.06% | +260.2% |
| BLU | New | BELLUS HEALTH INC NEW | $123,088,000 | – | 15,290,468 | +100.0% | 0.95% | – |
| ZYME | Buy | ZYMEWORKS INC | $120,624,000 | +12.9% | 7,359,690 | +100.0% | 0.93% | -40.1% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $119,344,000 | +94.8% | 3,886,194 | +100.0% | 0.92% | +3.4% |
| INBX | Buy | INHIBRX INC | $117,340,000 | +214.1% | 2,686,980 | +139.6% | 0.90% | +66.7% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $114,572,000 | +140.4% | 3,691,110 | +87.8% | 0.88% | +27.7% |
| ALBO | Buy | ALBIREO PHARMA INC | $109,936,000 | +49.3% | 4,720,278 | +100.0% | 0.85% | -20.7% |
| CCXI | Buy | CHEMOCENTRYX INC | $103,072,000 | +995.9% | 2,830,892 | +414.7% | 0.80% | +480.3% |
| Buy | COHERUS BIOSCIENCES INCnote 1.500% 4/1 | $102,978,000 | +108.6% | 9,000,000 | +100.0% | 0.79% | +10.7% | |
| NAUT | Buy | NAUTILUS BIOTECHNOLOGY INC | $94,390,000 | +72.5% | 18,222,302 | +104.5% | 0.73% | -8.4% |
| ARNA | New | ARENA PHARMACEUTICALS INC | $92,940,000 | – | 1,000,000 | +100.0% | 0.72% | – |
| ATHA | Buy | ATHIRA PHARMA INC | $89,280,000 | +177.8% | 6,851,832 | +100.0% | 0.69% | +47.5% |
| KOD | Buy | KODIAK SCIENCES INC | $88,196,000 | +99.2% | 1,040,304 | +125.5% | 0.68% | +5.8% |
| Buy | ICOSAVAX INC | $87,242,000 | +53.4% | 3,813,096 | +98.3% | 0.67% | -18.5% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $85,536,000 | +23.9% | 3,918,250 | +69.6% | 0.66% | -34.2% |
| QTNT | Buy | QUOTIENT LTD | $83,920,000 | +121.4% | 32,401,636 | +100.0% | 0.65% | +17.4% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $82,276,000 | +77.6% | 966,014 | +100.0% | 0.64% | -5.6% |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $79,232,000 | -8.9% | 19,807,758 | +100.0% | 0.61% | -51.6% |
| MORF | Buy | MORPHIC HLDG INC | $79,268,000 | +57.7% | 1,673,042 | +88.5% | 0.61% | -16.3% |
| OMIC | Buy | SINGULAR GENOMICS SYSTEMS IN | $77,078,000 | +124.1% | 6,667,648 | +116.9% | 0.59% | +18.8% |
| New | ISOPLEXIS CORP | $75,274,000 | – | 8,190,996 | +100.0% | 0.58% | – | |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $73,944,000 | – | 3,168,104 | +100.0% | 0.57% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $72,384,000 | – | 861,088 | +100.0% | 0.56% | – |
| IMTX | Buy | IMMATICS N.V | $67,200,000 | +106.8% | 5,000,000 | +100.0% | 0.52% | +9.7% |
| Buy | PROCEPT BIOROBOTICS CORP | $66,440,000 | +5.1% | 2,656,570 | +60.3% | 0.51% | -44.2% | |
| VRCA | Buy | VERRICA PHARMACEUTICALS INC | $66,142,000 | +46.6% | 7,220,824 | +100.0% | 0.51% | -22.3% |
| KRON | Buy | KRONOS BIO INC | $65,806,000 | +29.7% | 4,842,284 | +100.0% | 0.51% | -31.1% |
| RAIN | Buy | RAIN THERAPEUTICS INC | $63,978,000 | +68.6% | 4,967,238 | +95.8% | 0.49% | -10.5% |
| TARS | Buy | TARSUS PHARMACEUTICALS INC | $58,338,000 | +108.8% | 2,592,832 | +100.0% | 0.45% | +10.8% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $56,268,000 | +140.4% | 2,846,106 | +100.0% | 0.43% | +27.6% |
| LPTX | Buy | LEAP THERAPEUTICS INC | $54,926,000 | +61.6% | 16,952,992 | +100.0% | 0.42% | -14.2% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $54,822,000 | +51.5% | 811,082 | +60.4% | 0.42% | -19.6% |
| COGT | Buy | COGENT BIOSCIENCES INC | $54,718,000 | +104.0% | 6,377,500 | +100.0% | 0.42% | +8.2% |
| CMAX | Buy | CAREMAX INC | $54,520,000 | +66.7% | 7,099,050 | +109.7% | 0.42% | -11.6% |
| MGNX | Buy | MACROGENICS INC | $53,454,000 | +18.8% | 3,330,486 | +55.0% | 0.41% | -36.9% |
| VERU | Buy | VERU INC | $52,436,000 | +38.1% | 8,902,684 | +100.0% | 0.40% | -26.8% |
| NUVB | Buy | NUVATION BIO INC | $49,652,000 | +64.3% | 5,841,646 | +92.1% | 0.38% | -12.8% |
| LUNG | New | PULMONX CORP | $48,894,000 | – | 1,524,608 | +100.0% | 0.38% | – |
| NVTA | Sell | INVITAE CORP | $48,394,000 | -56.6% | 3,169,170 | -19.2% | 0.37% | -77.0% |
| SLDB | Buy | SOLID BIOSCIENCES INC | $46,944,000 | +46.4% | 26,825,104 | +100.0% | 0.36% | -22.3% |
| New | PYXIS ONCOLOGY INC | $42,652,000 | – | 3,888,228 | +100.0% | 0.33% | – | |
| Buy | CUE HEALTH INC | $42,392,000 | +127.1% | 3,161,214 | +100.0% | 0.33% | +20.7% | |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $40,650,000 | +55.4% | 188,128 | +32.8% | 0.31% | -17.4% |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $38,540,000 | +143.4% | 5,735,020 | +98.5% | 0.30% | +29.1% |
| New | SCIENCE 37 HOLDINGS INC | $37,410,000 | – | 3,000,000 | +100.0% | 0.29% | – | |
| ATNX | Buy | ATHENEX INC | $36,808,000 | -9.6% | 27,064,934 | +100.0% | 0.28% | -52.0% |
| TMCI | Buy | TREACE MED CONCEPTS INC | $36,542,000 | +9.9% | 1,960,372 | +58.6% | 0.28% | -41.6% |
| HCAT | Buy | HEALTH CATALYST INC | $35,976,000 | +22.1% | 908,008 | +54.2% | 0.28% | -35.3% |
| New | DICE THERAPEUTICS INC | $35,682,000 | – | 1,409,770 | +100.0% | 0.28% | – | |
| Buy | SOMALOGIC INC | $34,920,000 | +37.5% | 3,000,000 | +46.3% | 0.27% | -27.1% | |
| ADMA | Buy | ADMA BIOLOGICS INC | $33,652,000 | +124.6% | 23,866,774 | +80.0% | 0.26% | +19.3% |
| Buy | NUVALENT INC | $28,560,000 | +68.9% | 1,500,000 | +100.0% | 0.22% | -10.6% | |
| LYRA | Buy | LYRA THERAPEUTICS INC | $28,100,000 | -4.4% | 6,445,120 | +100.0% | 0.22% | -49.2% |
| VTRS | Buy | VIATRIS INC | $27,180,000 | +99.7% | 2,008,838 | +100.0% | 0.21% | +6.1% |
| SAVA | Buy | CASSAVA SCIENCES INCput | $26,220,000 | +322.4% | 600,000 | +500.0% | 0.20% | +124.4% |
| BCAB | Buy | BIOATLA INC | $25,958,000 | +3.7% | 1,322,400 | +55.6% | 0.20% | -45.1% |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $24,652,000 | +66.3% | 720,000 | +80.0% | 0.19% | -11.6% |
| Buy | NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $23,966,000 | +87.2% | 2,000,000 | +100.0% | 0.18% | -0.5% | |
| BIIB | Buy | BIOGEN INC | $23,320,000 | +69.6% | 97,200 | +100.0% | 0.18% | -10.0% |
| Buy | ABSCI CORPORATION | $23,154,000 | +34.8% | 2,823,552 | +91.2% | 0.18% | -28.1% | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $22,718,000 | +61.6% | 1,562,472 | +100.0% | 0.18% | -14.2% |
| MRUS | New | MERUS N V | $22,260,000 | – | 700,000 | +100.0% | 0.17% | – |
| Buy | SEMA4 HOLDINGS CORP | $22,300,000 | +17.5% | 5,000,000 | +100.0% | 0.17% | -37.7% | |
| Buy | IMMUNEERING CORP | $22,026,000 | +21.8% | 1,362,102 | +100.0% | 0.17% | -35.4% | |
| New | HYPERFINE INC | $21,750,000 | – | 3,000,000 | +100.0% | 0.17% | – | |
| GRPH | Buy | GRAPHITE BIO INC | $21,134,000 | +47.3% | 1,700,186 | +94.3% | 0.16% | -21.6% |
| AGRX | Buy | AGILE THERAPEUTICS INC | $20,788,000 | +35.9% | 42,588,970 | +167.5% | 0.16% | -27.9% |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $20,404,000 | +8.3% | 478,516 | -2.6% | 0.16% | -42.7% |
| SMIHU | Buy | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $19,900,000 | +98.0% | 2,000,000 | +100.0% | 0.15% | +4.8% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $19,800,000 | +65.1% | 705,608 | +100.0% | 0.15% | -12.1% |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $19,682,000 | +86.2% | 310,000 | +72.2% | 0.15% | -1.3% |
| RACB | Buy | RESEARCH ALLIANCE CORP II | $19,540,000 | +98.4% | 2,000,000 | +100.0% | 0.15% | +5.6% |
| BLSA | Buy | BCLS ACQUISITION CORP | $19,600,000 | +96.8% | 2,000,000 | +100.0% | 0.15% | +4.1% |
| Buy | TYRA BIOSCIENCES INC | $18,948,000 | +9.1% | 1,346,704 | +36.4% | 0.15% | -42.1% | |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $18,738,000 | +42.0% | 1,112,094 | +100.0% | 0.14% | -24.5% |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $18,706,000 | +73.5% | 1,064,700 | +100.0% | 0.14% | -8.3% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $17,760,000 | -16.4% | 459,614 | +16.8% | 0.14% | -55.7% |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $17,628,000 | – | 378,200 | +100.0% | 0.14% | – |
| NBTX | Buy | NANOBIOTIX SAsponsored ads | $17,168,000 | +42.6% | 2,119,600 | +100.0% | 0.13% | -24.6% |
| New | EQRX INC | $17,050,000 | – | 2,500,000 | +100.0% | 0.13% | – | |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $14,644,000 | – | 172,800 | +100.0% | 0.11% | – |
| Buy | SIGHT SCIENCES INC | $13,704,000 | +54.8% | 780,000 | +100.0% | 0.11% | -17.8% | |
| Buy | ASTRIA THERAPEUTICS INC | $13,762,000 | -20.6% | 2,553,397 | +30.3% | 0.11% | -57.9% | |
| CNCE | Buy | CONCERT PHARMACEUTICALS INC | $13,548,000 | +92.6% | 4,301,282 | +100.0% | 0.10% | +2.0% |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $13,372,000 | +39.9% | 2,387,990 | +92.1% | 0.10% | -25.9% |
| CRY | New | CRYOLIFE INC | $13,282,000 | – | 652,636 | +100.0% | 0.10% | – |
| ACCD | Buy | ACCOLADE INC | $12,060,000 | +2.2% | 457,548 | +63.5% | 0.09% | -45.6% |
| CLOV | Buy | CLOVER HEALTH INVESTMENTS CO | $11,160,000 | +0.7% | 3,000,000 | +100.0% | 0.09% | -46.6% |
| PRVB | Buy | PROVENTION BIO INC | $10,660,000 | +75.6% | 1,896,962 | +100.0% | 0.08% | -6.8% |
| ONCR | Buy | ONCORUS INC | $10,538,000 | +2.6% | 1,999,624 | +81.8% | 0.08% | -45.6% |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $10,406,000 | +25.4% | 588,236 | +100.0% | 0.08% | -33.9% |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $10,234,000 | +3.0% | 2,454,034 | +95.6% | 0.08% | -45.1% |
| New | ENVVENO MEDICAL CORPORATION | $10,300,000 | – | 1,563,230 | +100.0% | 0.08% | – | |
| Buy | DA32 LIFE SCNCE TEC ACQSTN C | $9,810,000 | +99.6% | 1,000,000 | +100.0% | 0.08% | +7.0% | |
| PRTA | Buy | PROTHENA CORP PLC | $9,880,000 | +38.7% | 200,000 | +100.0% | 0.08% | -26.2% |
| DNAY | Buy | CODEX DNA INC | $9,180,000 | +94.1% | 850,000 | +100.0% | 0.07% | +2.9% |
| HSAQ | Buy | HEALTH SCIENCES ACQ CORP 2 | $9,072,000 | +103.8% | 900,000 | +100.0% | 0.07% | +7.7% |
| Buy | DARIOHEALTH CORP | $8,504,000 | +90.0% | 655,738 | +100.0% | 0.07% | +1.5% | |
| NEPT | Buy | NEPTUNE WELLNESS SOLUTIONS I | $8,246,000 | +35.6% | 20,111,042 | +100.0% | 0.06% | -27.3% |
| Buy | RAPID MICRO BIOSYSTEMS INC | $8,208,000 | +27.0% | 771,386 | +120.4% | 0.06% | -33.0% | |
| New | SONENDO INC | $7,702,000 | – | 1,337,010 | +100.0% | 0.06% | – | |
| ACHL | Buy | ACHILLES THERAPEUTICS PLCsponsored ads | $7,568,000 | +28.6% | 1,510,750 | +100.0% | 0.06% | -31.8% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $6,076,000 | +129.2% | 160,840 | +100.0% | 0.05% | +20.5% |
| ZY | ZYMERGEN INC | $5,909,000 | -49.2% | 883,332 | 0.0% | 0.05% | -72.8% | |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $5,776,000 | -35.8% | 250,000 | -17.1% | 0.04% | -65.6% |
| TARA | Buy | PROTARA THERAPEUTICS INC | $5,692,000 | +95.1% | 843,282 | +100.0% | 0.04% | +4.8% |
| New | PEAR THERAPEUTICS INC | $5,742,000 | – | 926,232 | +100.0% | 0.04% | – | |
| Buy | SURROZEN INC | $5,326,000 | +50.5% | 826,892 | +65.4% | 0.04% | -19.6% | |
| VYNE | Buy | VYNE THERAPEUTICS INC | $4,444,000 | +37.2% | 4,356,044 | +86.9% | 0.03% | -27.7% |
| DCPH | New | DECIPHERA PHARMACEUTICALS INcall | $3,908,000 | – | 400,000 | +100.0% | 0.03% | – |
| NVRO | Sell | NEVRO CORP | $3,720,000 | -87.7% | 45,892 | -82.3% | 0.03% | -93.4% |
| RACE | Buy | FERRARI N V | $3,210,000 | +147.5% | 12,400 | +100.0% | 0.02% | +31.6% |
| ITOS | New | ITEOS THERAPEUTICS INC | $1,862,000 | – | 40,000 | +100.0% | 0.01% | – |
| MOTS | Buy | MOTUS GI HLDGS INC | $1,682,000 | +35.4% | 3,601,084 | +100.0% | 0.01% | -27.8% |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $1,452,000 | +55.5% | 279,780 | +100.0% | 0.01% | -21.4% |
| Buy | ROCKLEY PHOTONICS HOLDINGS L*w exp 08/11/202 | $1,210,000 | +1.3% | 1,000,000 | +100.0% | 0.01% | -47.1% | |
| New | MINERVA SURGICAL INC | $902,000 | – | 175,536 | +100.0% | 0.01% | – | |
| Buy | SOMALOGIC INC*w exp 08/31/202 | $734,000 | +93.2% | 220,000 | +100.0% | 0.01% | 0.0% | |
| PHVS | Buy | PHARVARIS N V | $778,000 | +62.4% | 54,000 | +100.0% | 0.01% | -14.3% |
| BFLYWS | Buy | BUTTERFLY NETWORK INC*w exp 02/12/202 | $592,000 | -7.8% | 466,666 | +100.0% | 0.01% | -44.4% |
| New | EQRX INC*w exp 12/17/202 | $532,000 | – | 500,000 | +100.0% | 0.00% | – | |
| Buy | SURROZEN INC*w exp 08/01/203 | $384,000 | +102.1% | 333,332 | +100.0% | 0.00% | 0.0% | |
| CMAXW | Buy | CAREMAX INC*w exp 06/08/202 | $168,000 | -1.2% | 120,000 | +100.0% | 0.00% | -50.0% |
| FREQ | Exit | FREQUENCY THERAPEUTICS INC | $0 | – | -222,222 | -100.0% | -0.02% | – |
| Exit | IMAGO BIOSCIENCES INC | $0 | – | -125,000 | -100.0% | -0.04% | – | |
| LSAQ | Exit | LIFESCI ACQUISITION II CORP | $0 | – | -300,000 | -100.0% | -0.04% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -89,283 | -100.0% | -0.05% | – |
| ATEC | Exit | ALPHATEC HLDGS INC | $0 | – | -430,900 | -100.0% | -0.08% | – |
| PSTX | Exit | POSEIDA THERAPEUTICS INC | $0 | – | -787,745 | -100.0% | -0.08% | – |
| TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -320,440 | -100.0% | -0.09% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -375,256 | -100.0% | -0.15% | – |
| PODD | Exit | INSULET CORP | $0 | – | -44,522 | -100.0% | -0.18% | – |
| CMLTU | Exit | CM LIFE SCIENCES III INCunit 04/30/2028 | $0 | – | -1,250,000 | -100.0% | -0.19% | – |
| HCAQ | Exit | HEALTHCOR CATALIO ACQU CORP | $0 | – | -1,500,000 | -100.0% | -0.22% | – |
| CCXI | Exit | CHEMOCENTRYX INCcall | $0 | – | -923,200 | -100.0% | -0.23% | – |
| NTRA | Exit | NATERA INC | $0 | – | -160,000 | -100.0% | -0.26% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -885,818 | -100.0% | -0.32% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -7,695,505 | -100.0% | -0.55% | – |
| BEAM | Exit | BEAM THERAPEUTICS INC | $0 | – | -537,635 | -100.0% | -0.68% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -2,259,224 | -100.0% | -1.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 40 | Q1 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 37 | Q1 2023 | 14.0% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| ALDEYRA THERAPEUTICS SHARES | 33 | Q1 2023 | 3.3% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| ADMA BIOLOGICS SHARES | 27 | Q1 2023 | 1.4% |
| FERRARI SHARES | 26 | Q2 2022 | 0.0% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| Bellerophon Therapeutics, Inc. | March 14, 2023 | 930,000 | 8.9% |
| CymaBay Therapeutics, Inc. | March 10, 2023 | 5,278,962 | 5.6% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| Acrivon Therapeutics, Inc. | February 14, 2023 | 3,007,858 | 14.4% |
| ADMA BIOLOGICS, INC. | February 14, 2023 | 11,900,255 | 5.4% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| Aldeyra Therapeutics, Inc. | February 14, 2023 | 11,350,085 | 19.4% |
| AMICUS THERAPEUTICS, INC. | February 14, 2023 | 27,642,917 | 9.8% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-06-06 |
| SC 13D/A | 2023-06-06 |
| 4 | 2023-06-02 |
| SC 13D/A | 2023-06-02 |
| 4 | 2023-06-01 |
| SC 13D/A | 2023-05-30 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-25 |
| 4 | 2023-05-23 |
| 3 | 2023-05-18 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.